Shawna McCallin, PhD

Shawna McCallin is a scientist at the Swiss Federal Institute of Technology in Lausanne (EPFL), Switzerland who has previously been involved in two phage clinical trials for E. coli diarrhea and S. aureus carriage. She has extensively studied commercial phage preparations from Russia and Georgia, with a focus on S. aureus phage diversity. As of recently, she is working on clinical and regulatory aspects of phage therapy and expanding her phage research to the microbiome. She is a member of the editorial board of the new scientific journal PHAGE: Therapy, Applications, and Research, and a member of the executive board of the ISVM.